3 ms·
...which means that the optimal strategy is still go ahead with the Oxford-AstraZeneca phase 3 trial DESPITE these disappointing results, because they don't hav
by koheripbal 6y ago
...which means that the optimal strategy is still go ahead with the Oxford-AstraZeneca phase 3 trial DESPITE these disappointing results, because they don't have another vaccine in SA and they really need to reduce hospitalizations and transmissability.
Unfortunately, the vaccine review system is not setup to allow such nuanced approvals.
- rossdavidh 6y agoI wouldn't be surprised if that's what SA does; the health minister kind of signaled that it may be resumed. I'm sure they're at least considering it. Normal approval processes for vaccines are getting modified all over the place, nowadays.